The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Esophageal cancer (EC) is one of the most aggressive malignant tumors of the gastrointestinal tract. There are two distinct histological types of EC: esophageal squamous cell carcinoma and adenocarcinoma of the esophagus. Etiologic factors and the patterns of incidence of both subtypes are different. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) play an important role in esophageal carcinogenesis. Gellatinases MMP-2 and MMP-9 are able to degrade collagen IV from basement membranes and extracellular matrix which is related to tumor progression, including invasion, metastasis, growth and angiogenesis. It has been shown that increased expression of MMPs plays a crucial role in the development of several human malignancies, including esophageal cancer. The activity of MMPs is regulated by their endogenous natural inhibitors (TIMPs). Among these, the roles of TIMP-1 and TIMP-2 in EC development, tumor progression and formation of metastases have been most extensively characterized and best recognized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez, D. E., Alonso, D. F., Yoshiji, H., & Thorgeirsson, U. P. (1997) · PubMed · Cited by 1,508
Pohl, H., & Welch, H. G. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji024 · Cited by 1,270
Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., & Goldberg, G. I. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71480-4 · Cited by 1,109
Goldberg, G. I., Marmer, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S., & He, C. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8207 · Cited by 586
Epidemiology and Pathogenesis of Esophageal Cancer
Holmes, R. S., & Vaughan, T. L. (2007) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2006.09.003 · Cited by 527
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
Coleman, M. P., Gatta, G., Verdecchia, A., Estève, J., Sant, M., Storm, H., Allemani, C., Ciccolallo, L., Santaquilani, M., & Berrino, F. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg756 · Cited by 483
Ii, M., Yamamoto, H., Adachi, Y., Maruyama, Y., & Shinomura, Y. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100103 · Cited by 443
Epidemiology of upper gastrointestinal malignancies
CREW, K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.04.021 · Cited by 323
Role of Matrix Metalloproteinases in Abdominal Aortic Aneurysmsa
THOMPSON, R. W., & PARKS, W. C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb33307.x · Cited by 306
Lindblad, M., Rodríguez, L. A. G., & Lagergren, J. (2005) · Cancer Causes & Control · doi:10.1007/s10552-004-3485-7 · Cited by 300
Apte, S. S., Olsen, B. R., & Murphy, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14313 · Cited by 295
Matrix metalloproteinases degrade myelin basic protein
Chandler, S., Coates, R., Gearing, A., Lury, J., Wells, G., & Bone, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12173-0 · Cited by 294
Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer
Murray, G. I., Duncan, M. E., O'Neil, P., McKay, J. A., Melvin, W. T., & Fothergill, J. E. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<256::aid-path115>3.0.co;2-a · Cited by 288
Ahonen, M., Baker, A. H., & Kähäri, V. (1998) · PubMed · Cited by 266
Metalloproteinase inhibitors and the prevention of connective tissue breakdown
Cawston, T. E. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00015-0 · Cited by 257
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
Anand‐Apte, B., Pepper, M. S., Voest, E. E., Montesano, R., Olsen, B. R., Murphy, G., Apte, S., & Zetter, B. R. (1997) · PubMed · Cited by 251
Matrix Metalloproteinases in Brain Injury
ROSENBERG, G. A. (1995) · Journal of Neurotrauma · doi:10.1089/neu.1995.12.833 · Cited by 218
The Matrix Metalloproteinase Family
Woessner, J. F. (1998) · Matrix Metalloproteinases · doi:10.1016/b978-012545090-4/50002-1 · Cited by 217
Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
Talvensaari-Mattila, A., Pääkkö, P., & Turpeenniemi-Hujanen, T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601238 · Cited by 217
Strauss, B. H., Robinson, R., Batchelor, W. B., Chisholm, R. J., Ravi, G., Natarajan, M. K., Logan, R. A., Mehta, S. R., Levy, D. E., Ezrin, A. M., et al. (1996) · Circulation Research · doi:10.1161/01.res.79.3.541 · Cited by 162
Bigg, H. F., Shi, Y. E., Liu, Y. E., Steffensen, B., & Overall, C. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15496 · Cited by 160
Mayne, S. T., & Silvera, S. A. N. (2002) · Journal of Nutrition · doi:10.1093/jn/132.11.3467s · Cited by 149
Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer
Kubben, F. J. G. M., Sier, C. F. M., Meijer, M. J. W., van den Berg, M., van der Reijden, J. J., Griffioen, G. G., van de Velde, C. J. H., Lamers, C. B. H. W., & Verspaget, H. W. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603307 · Cited by 122
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma
Li, Y., Ma, J., Guo, Q., Duan, F.-L., Fuai, T., Zheng, P., Zhao, Z., & Lu, G. (2009) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2008.00928.x · Cited by 105
Gu, Z., Li, J., Li, M., Gu, J., Shi, X., Ke, Y., & Chen, K. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50018.x · Cited by 103
Salmela, M. T., Karjalainen‐Lindsberg, M., Puolakkainen, P. A., & Saarialho‐Kere, U. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1929 · Cited by 103
Ishibashi, Y., Matsumoto, T., Niwa, M., Suzuki, Y., Omura, N., Hanyu, N. N., Nakada, K., Yanaga, K. K., Yamada, K., Ohkawa, K., et al. (2004) · Cancer · doi:10.1002/cncr.20593 · Cited by 99
Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice.
Martin, D. C., Rüther, U., Sanchez-Sweatman, O. H., Orr, F. W., & Khokha, R. (1996) · PubMed · Cited by 98
Mroczko, B., Kozłowski, M., Groblewska, M., Łukaszewicz‐Zając, M., Nikliński, J., Jelski, W., Laudanski, J., Chyczewski, L., & Szmitkowski, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.11.023 · Cited by 91
Self-citationPredictive and prognostic molecular markers in outcome of esophageal cancer
Vallböhmer, D., & Lenz, H. (2006) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2006.00622.x · Cited by 76
Koyama, H., Iwata, H., Kuwabara, Y., Iwase, H., Kobayashi, S., & Fujii, Y. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00297-5 · Cited by 71
Active MMP‐2 effectively identifies the presence of colorectal cancer
Murnane, M. J., Cai, J., Shuja, S., McAneny, D. B., Klepeis, V. E., & Willett, J. B. (2009) · International Journal of Cancer · doi:10.1002/ijc.24682 · Cited by 56
Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma
Mukherjee, S., Roth, M. J., Dawsey, S. M., Yan, W., Rodriguez‐Canales, J., Erickson, H. S., Hu, N., Goldstein, A. M., Taylor, P. R., Richardson, A. M., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-91 · Cited by 44
O'BYRNE, E. M., Parker, D. T., Roberts, E. D., GOLDBERG, R. L., MacPherson, L. J., Blancuzzi, V., Wilson, D. E., Singh, H. N., Ludewig, R., & Ganu, V. (1995) · Inflammation Research · doi:10.1007/bf01778290 · Cited by 38
Sharma, R., Chattopadhyay, T. K., Mathur, M., & Ralhan, R. (2004) · Oncology · doi:10.1159/000081331 · Cited by 35
An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma
Miyazaki, T., Kato, H., Nakajima, M., Faried, A., Takita, J., Sohda, M., Fukai, Y., Yamaguchi, S., Masuda, N., Manda, R., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602185 · Cited by 32
Lyronis, I. D., Baritaki, S., Bizakis, I., Tsardi, M., & Spandidos, D. A. (2005) · The International Journal of Biological Markers · doi:10.1177/172460080502000102 · Cited by 31
Apte, S., Olsen, B. R., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45754-1 · Cited by 27
Augoff, K., Grabowski, K., Rabczyński, J., Kolondra, A., Taboła, R., & Sikorski, A. F. (2009) · Cancer Investigation · doi:10.1080/07357900802527221 · Cited by 21
Chen, Y., Chang, W. W., Wu, I., Li, L., Yang, S., Chen, J. Y., Hsu, M.-C., Chen, S.-H., Wu, D., Lee, J., et al. (2010) · PubMed · Cited by 11
Cited by
Zhang, W., Nandakumar, N., Shi, Y., Manzano, M., Smith, A., Graham, G., Gupta, S., Vietsch, E. E., Laughlin, S. Z., Wadhwa, M., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005049 · Cited by 360
Wang, L., Chen, G., Lu, X., Wang, S., Han, S., Li, Y., Ping, G., Jiang, X., Li, H., Yang, J., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.036 · Cited by 64
Naranjo, J. D., Saldin, L. T., Sobieski, E., Quijano, L. M., Hill, R. C., Chan, P. G., Torres, C., Dziki, J. L., Cramer, M. C., Lee, Y. C., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba4526 · Cited by 38
Metadata
- Authors
- Groblewska, M., Siewko, M., Mroczko, B., & Szmitkowski, M.
- Venue
- Folia Histochemica et Cytobiologica
- Publisher
- VM Media SP. zo.o VM Group SK
- Published
- 2012-04-25
- Volume
- 50
- Issue
- 1
- Pages
- 12-19
- ISSN
- 0015-5586 (ISSN-L)
- 1897-5631
- 0239-8508
- OpenAlex
- W2129353670
- Cited by
- 180
- References
- 43
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.